Literature DB >> 27334146

"Exercise as medicine" in chronic kidney disease.

T J Wilkinson1, N F Shur1, A C Smith1.   

Abstract

Exercise and physical activity are increasingly becoming key tools in the treatment and prevention of several medical conditions including arthritis and diabetes; this notion has been termed "exercise as medicine". Exercise has favorable effects on reducing cardiovascular risk, inflammation, cachexia, and hypertension, in addition to increasing physical functioning, strength, and cardio-respiratory capacity. Chronic kidney disease, a condition that affects around 10% of the population, is often overlooked as a target for exercise-based therapy. Despite the vast range of severity in kidney disease (e.g., pre-dialysis, dialysis, transplant), exercise has a potential role in all patients suffering from the condition. In this review, we summarise the important role exercise may have in the clinical management of kidney disease and how this form of 'medicine' should be best administered and 'prescribed'.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Chronic kidney disease; cachexia; dialysis; exercise; exercise as medicine; physical activity; renal

Mesh:

Year:  2016        PMID: 27334146     DOI: 10.1111/sms.12714

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  18 in total

1.  "A Learned Soul to Guide Me": The Voices of Those Living with Kidney Disease Inform Physical Activity Programming.

Authors:  Trisha L Parsons; Clara Bohm; Katherine Poser
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

2.  Association of Fitness With Racial Differences in Chronic Kidney Disease.

Authors:  Amanda E Paluch; Lindsay R Pool; Tamara Isakova; Cora E Lewis; Rupal Mehta; Pamela J Schreiner; Stephen Sidney; Myles Wolf; Mercedes R Carnethon
Journal:  Am J Prev Med       Date:  2019-05-21       Impact factor: 5.043

3.  Long-term intradialytic hybrid exercise training on fatigue symptoms in patients receiving hemodialysis therapy.

Authors:  Stefania S Grigoriou; Argyro A Krase; Christina Karatzaferi; Christoforos D Giannaki; Eleftherios Lavdas; Georgia I Mitrou; Saul Bloxham; Ioannis Stefanidis; Giorgos K Sakkas
Journal:  Int Urol Nephrol       Date:  2021-01-02       Impact factor: 2.370

4.  Influence of sex differences in maintenance-hemodialysis participants on motivation of exercise therapy implementation: a multicenter cross-sectional study.

Authors:  Tomoya Yamaguchi; Hiroki Yabe; Kenichi Kono; Yoshifumi Moriyama; Tetsuya Yamada
Journal:  J Nephrol       Date:  2022-08-18       Impact factor: 4.393

5.  Association Between Exercise Self-Efficacy and Health-Related Quality of Life Among Dialysis Patients: A Cross-Sectional Study.

Authors:  Fan Zhang; Jing Liao; Weihong Zhang; Liuyan Huang
Journal:  Front Psychol       Date:  2022-06-20

6.  Effects of pre-dialysis resistance training on sarcopenia, inflammatory profile, and anemia biomarkers in older community-dwelling patients with chronic kidney disease: a randomized controlled trial.

Authors:  André Bonadias Gadelha; Matteo Cesari; Hugo Luca Corrêa; Rodrigo Vanerson Passos Neves; Caio Victor Sousa; Lysleine Alves Deus; Michel Kendy Souza; Andrea Lucena Reis; Milton Rocha Moraes; Jonato Prestes; Herbert Gustavo Simões; Rosangela Vieira Andrade; Gislane Ferreira Melo; Thiago Santos Rosa
Journal:  Int Urol Nephrol       Date:  2021-02-20       Impact factor: 2.370

7.  Salvianolic acid B attenuates renal interstitial fibrosis by regulating the HPSE/SDC1 axis.

Authors:  Yang Hu; Man Wang; Yunzheng Pan; Qingju Li; Li Xu
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

8.  Satellite cell function, intramuscular inflammation and exercise in chronic kidney disease.

Authors:  Tom F O'Sullivan; Alice C Smith; Emma L Watson
Journal:  Clin Kidney J       Date:  2018-07-30

9.  Twelve weeks of supervised exercise improves self-reported symptom burden and fatigue in chronic kidney disease: a secondary analysis of the 'ExTra CKD' trial.

Authors:  Thomas J Wilkinson; Emma L Watson; Douglas W Gould; Soteris Xenophontos; Amy L Clarke; Barbara P Vogt; João L Viana; Alice C Smith
Journal:  Clin Kidney J       Date:  2018-08-13

10.  Altered Amino Acid Metabolism in Patients with Cardiorenal Syndrome Type 2: Is It a Problem for Protein and Exercise Prescriptions?

Authors:  Roberto Aquilani; Roberto Maestri; Maurizia Dossena; Maria Teresa La Rovere; Daniela Buonocore; Federica Boschi; Manuela Verri
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.